Hiroshi Nishihara

Clinical and Translational Research Center

Websitehttps://k-ris.keio.ac.jp/html/100001653_en.html

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Hiroshi Nishihara is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

4075 Citations
34 h-Index
190 Article
8 Comment/debate
8 Letter
3 Review article

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
Morimoto, H., Hida, Y., Maishi, N., Nishihara, H., Hatanaka, Y., Li, C., Matsuno, Y., Nakamura, T., Hirano, S. & Hida, K., 2021 May, In: Thoracic Cancer. 12, 9, p. 1347-1357 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using ¹²⁵I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)
Takagi, H., Zhao, S., Muto, S., Yokouchi, H., Nishihara, H., Harada, T., Yamaguchi, H., Mine, H., Watanabe, M., Ozaki, Y., Inoue, T., Yamaura, T., Fukuhara, M., Okabe, N., Matsumura, Y., Hasegawa, T., Osugi, J., Hoshino, M., Higuchi, M., Shio, Y. & 22 others, Kanno, R., Aoki, M., Tan, C., Shimoyama, S., Yamazaki, S., Kikuchi, H., Sakakibara-Konishi, J., Oizumi, S., Harada, M., Akie, K., Sugaya, F., Fujita, Y., Takamura, K., Kojima, T., Honjo, O., Minami, Y., Nishimura, M., Dosaka-Akita, H., Nakamura, K., Inano, A., Isobe, H. & Suzuki, H., 2021 Mar, In: Lung Cancer. 153, p. 134-142 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Diffuse-Type Tenosynovial Giant Cell Tumor Arising in the Temporomandibular Joint Extending to the External Auditory Canal: A Case Report and Literature Review
Suzuki, S., Tsuda, H., Bandoh, N., Goto, T., Uemura, A., Aoyama, T., Nishio, A., Makino, S., Yamaguchi, T., Aimono, E., Nishihara, H. & Harabuchi, Y., 2021, (Accepted/In press) In: Ear, Nose and Throat Journal.
Research output: Contribution to journal › Article › peer-review

Open Access
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Nakamura, K., Aimono, E., Oba, J., Hayashi, H., Tanishima, S., Hayashida, T., Chiyoda, T., Kosaka, T., Hishida, T., Kawakubo, H., Kitago, M., Okabayashi, K., Funakoshi, T., Okita, H., Ikeda, S., Takaishi, H. & Nishihara, H., 2021 Apr, In: Medical Oncology. 38, 4, 36.
Research output: Contribution to journal › Article › peer-review

Open Access
First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion
Shojo, K., Kosaka, T., Nakamura, K., Hongo, H., Kobayashi, H., Mikami, S., Nishihara, H. & Oya, M., 2021 May, In: IJU Case Reports. 4, 3, p. 176-179 4 p.
Research output: Contribution to journal › Article › peer-review

Open Access

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

Diffuse-Type Tenosynovial Giant Cell Tumor Arising in the Temporomandibular Joint Extending to the External Auditory Canal: A Case Report and Literature Review

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

First case of ductal adenocarcinoma of the prostate with MAP3K1 homozygous deletion

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using ¹²⁵I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)